3.9 Article

Recalibration and validation of the SCORE risk chart in the Australian population: the AusSCORE chart

出版社

SAGE PUBLICATIONS LTD
DOI: 10.1097/HJR.0b013e32832cd9cb

关键词

Blue Mountains Eye Study; cardiovascular disease; mortality; risk prediction; Systematic COronary Risk Evaluation

资金

  1. Australian Postgraduate Award scholarship
  2. NIHR Cambridge Biomedical Research Centre

向作者/读者索取更多资源

Background Development of a validated risk prediction model for future cardiovascular disease (CVD) in Australians is a high priority for cardiovascular health strategies. Design Recalibration of the SCORE (Systematic COronary Risk Evaluation) risk chart based on Australian national mortality data and average major CVD risk factor levels. Methods Australian national mortality data (2003-2005) were used to estimate 10-year cumulative CVD mortality rates for people aged 40-74 years. Average age-specific and sex-specific levels of systolic blood pressure, total cholesterol and prevalence of current smoking were generated from data obtained in eight Australian large-scale population-based surveys undertaken from the late 1980s. The SCORE risk chart was then recalibrated by applying hazard ratios for 10-year CVD mortality obtained in the SCORE project. Discrimination and calibration of the recalibrated model was evaluated and compared with that of the original SCORE and Framingham equations in the Blue Mountains Eye Study in Australia using Harrell's c and Hosmer-Lemeshow chi(2) statistics, respectively. Results An Australian risk prediction chart for CVD mortality was derived. Among 1998 Blue Mountains Eye Study participants aged 49-74 years with neither CVD nor diabetes at baseline, the Harrell's c statistics for the Australian risk prediction chart for CVD mortality were 0.76 (95% confidence interval: 0.69-0.84) and 0.71 (confidence interval: 0.62-0.80) in men and women, respectively. The corresponding Hosmer-Lemeshow chi(2) statistics, the measure of calibration, were 2.32 (P=0.68) and 7.43 (P=0.11), which were superior to both the SCORE and Framingham equations. Conclusion This new tool provides a valid and reliable method to predict risk of CVD mortality in the general Australian population. Eur J Cardiovasc Prev Rehabil 16:562-570 (C) 2009 The European Society of Cardiology

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

3.9
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据